http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-1251204-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate | 1991-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1995-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_406d30279ec99d45d8163d493e25fa41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d70a8e162aaab9939b0b4607ceb6bb3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57ca85aa9c12ebb0fa454e475096b425 |
| publicationDate | 1995-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IT-1251204-B |
| titleOfInvention | DRUG FOR HUMAN USE, WITH CONTRACEPTIVE AND REGULATORY ACTION OF THE MENSTRUAL CYCLE, WITH PREVENTIVE AND THERAPEUTIC ONCOSTATIC ACTION, IN BREAST CANCERS AND IN MELANOMA, AND WITH ANTI-KINETOSE ACTION AND SYNTHESIS METHOD |
| abstract | The present invention relates to a drug for human use, with contraceptive and regulatory action of the menstrual cycle characterized in that it provides for the use of N-acetyl-5methoxytryptamine or melatonin in the pro die dose of 100-200 mg, N-acetyl- 2bromo-5methoxytryptamine or 2-bromomelatonin in the pro die dose of 25-50 mg. N-acetyl-2-iodo-5-methoxytryptamine or 2-iodomelatonin, in the pro-dose of 20-40 mg, in association with a progestogen. The administration should be done for 23 days, using the combination of 2-iodomelatonin and / or melatonin and / or 2-bromomelatonin and a progestogen, followed by 5 days of administration of only 2-iodomelatonin and / or melatonin and / or 2-bromomelatonin; with oncostatic, preventive and therapeutic action, in breast tumors and melanoma, characterized by the use of 2-iodomelatonin, melatonin and 2-bromomelatonin respectively at the doses 20-40 mg, 100-200 mg, 25-50 mg doses per day ; anti-kinetic action, characterized by the use of 2-iodomelatonin in the pro die dose of 2.5 mg, melatonin, in the pro die dose of 10 mg and 2-bromomelatonin in the pro die dose of 3.5 mg, alone and / or in combination Acetyl Coenzyme A- (AcCoA) - in a dose of 8-10 mg, pro die. |
| priorityDate | 1991-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.